| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | budesonide (Entocort CR®) |
| Formulation | 3 mg capsule |
| Reference number | 3614 |
| Indication | Induction of remission in patients with active microscopic colitis. |
| Company | Tillotts Pharma UK Ltd |
| BNF chapter | Gastro-intestinal system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 31/01/2022 |